References
- Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368–376. http://dx.doi.org/10.1136/jnnp.2007.131045
- Ossig C, Reichmann H. Treatment of Parkinson's disease in the advanced stage. J Neural Transm (Vienna). 2013;120(4):523–529.
- Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease. J Am Med Assoc. 2009;301(1):63–73..
- Clarke CE, Worth P, Grosset D, et al. Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease. Parkinsonism Relat Disord. 2009;15(10):728–727.
- Eggert K, Schrader C, Hahn M, et al. Continuous jejunal levodopa infusion in patients with advanced Parkinson disease: practical aspects and outcome of motor and non-motor complications. Clin Neuropharmacol. 2008;31(3):151–166.
- Antonini A, Isaias IU, Canesi M, et al. Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome. Mov Disord. 2007;22(8):1145–1149.
- Marshall T, Pugh A, Fairchild A, et al. Patient preferences for device-aided treatments indicated for advanced Parkinson disease. Value Health. 2017;20(10):1383–1393..
- Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427–442.
- Deuschl G. Fitting the scientific tools of our speciality: the New Movement Disorder Society unified Parkinson's disease rating scale. Mov Disord. 2008;23(15):2109–2110.
- Akbostancı MC. Parkinson hastalığının değerlendirilmesinde kullanılan ölçekler ve yeni UPDRS. Türkiye Klinikleri Nöroloji. 2008;1(4):115–117.
- Folstein MF, Folstein S, Mc Hugh PR. “Mini Mental State.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198..
- Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571..